The AI intelligence platform
TLDRocket reads all relevant sources, removes duplicate coverage, and publishes a short neutral summary of every story, linking back to the original. Free, no spam, unsubscribe anytime.
Every story also updates live profiles event timelines weekly rankings the AI Market Index
OpenAI 1 year ago 50
OpenAI and Retro Bio used a specialized AI model called GPT-4b micro to design proteins for stem cell therapy and longevity research. The model accelerated protein engineering by reducing the iteration cycles required to identify candidates with desired biological properties. This enables faster development timelines for therapies targeting cellular regeneration and aging-related conditions.
The daily briefing
TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.
TLDRocket
26 October 2026
Anthropic’s IPO filing set the tone for the day’s biggest AI story, turning what’s usually backroom capital math into a public document full of signals. In its S-1, the company behind Claude reported $16.3 billion in revenue for the first half of 2026 and a net loss of $80.7 billion, while outlining a Nasdaq listing under ticker ANT. The filing also spotlights founder voting control and a safety-first governance structure—less “investors, trust us” than “here’s exactly how decisions stay constrained,” a posture that’s likely to matter as expectations shift from model demos to boardroom risk.
Read the full briefing →